Liver cancer drug shows promise in Late-Stage trial
Disease control
Completed
This study tested the drug sorafenib in 50 adults with advanced liver cancer that could not be removed by surgery and had worsened after at least one prior treatment. The goal was to see if sorafenib could slow cancer growth and to check its safety. Participants took sorafenib pi…
Phase: PHASE2 • Sponsor: Bo Hyun Kim • Aim: Disease control
Last updated Apr 26, 2026 20:03 UTC